Anti-SLC22A18 antibody produced in mouse
SIGMA/SAB1409387 - purified immunoglobulin, buffered aqueous solution
Synonym: BWR1A; BWSCR1A; DKFZp667A184; HET; IMPT1; ITM; ORCTL2; SLC22A1L; TSSC5
Product Type: Chemical
Western Blotting Western Blot analysis of SLC22A18 expression in transfected 293T cell line by SLC22A18 polyclonal antibody. Lanes Lane 1: SLC22A18 transfected lysate (46.64 kDa). Lane 2: Non-transfected lysate.
| antibody form | purified immunoglobulin |
| antibody product type | primary antibodies |
| biological source | mouse |
| clone | polyclonal |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| mol wt | antigen 44.8 kDa |
| NCBI accession no. | NM_002555.3   |
| shipped in | dry ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | western blot: 1 μg/mL |
| UniProt accession no. | Q96BI1 |
| General description: | This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region as well as the transport of chloroquine- and quinidine-related compounds in the kidney. Two alternative transcripts encoding the same isoform have been described. (provided by RefSeq) |
| Immunogen: | SLC22A18 (NP_002546.2, 1 a.a. ~ 424 a.a) full-length human protein. Sequence MQGARAPRDQGQSPGRMSALGRSSV |
| Physical form: | Solution in phosphate buffered saline, pH 7.4 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |